Guggenheim Capital LLC Sells 6,495 Shares of Cardinal Health Inc (NYSE:CAH)
Guggenheim Capital LLC reduced its stake in shares of Cardinal Health Inc (NYSE:CAH) by 2.1% in the 1st quarter, Holdings Channel reports. The firm owned 309,928 shares of the company’s stock after selling 6,495 shares during the quarter. Guggenheim Capital LLC’s holdings in Cardinal Health were worth $14,858,000 at the end of the most recent quarter.
Other large investors also recently made changes to their positions in the company. Manchester Financial Inc. lifted its stake in shares of Cardinal Health by 50.2% in the 1st quarter. Manchester Financial Inc. now owns 610 shares of the company’s stock valued at $29,000 after acquiring an additional 204 shares during the last quarter. Liberty Wealth Management LLC increased its stake in Cardinal Health by 307.1% in the 1st quarter. Liberty Wealth Management LLC now owns 635 shares of the company’s stock worth $30,000 after purchasing an additional 479 shares during the period. WASHINGTON TRUST Co bought a new stake in Cardinal Health in the first quarter valued at approximately $30,000. Fieldpoint Private Securities LLC lifted its position in Cardinal Health by 80.3% in the fourth quarter. Fieldpoint Private Securities LLC now owns 660 shares of the company’s stock valued at $33,000 after purchasing an additional 294 shares during the last quarter. Finally, Procyon Private Wealth Partners LLC purchased a new stake in shares of Cardinal Health during the fourth quarter valued at approximately $33,000. 84.30% of the stock is owned by institutional investors and hedge funds.
A number of equities research analysts recently commented on CAH shares. Zacks Investment Research lowered shares of Cardinal Health from a “buy” rating to a “hold” rating and set a $61.00 price target for the company. in a report on Tuesday, May 12th. Mizuho upped their price objective on shares of Cardinal Health from $50.00 to $56.00 and gave the company a “neutral” rating in a research note on Tuesday, May 12th. Credit Suisse Group cut Cardinal Health to a “hold” rating and set a $53.00 target price on the stock. in a research note on Wednesday, April 22nd. Bank of America raised Cardinal Health to a “buy” rating in a research report on Friday, May 15th. Finally, UBS Group upgraded Cardinal Health from a “neutral” rating to a “buy” rating and increased their price objective for the stock from $48.00 to $64.00 in a report on Friday, May 15th. One investment analyst has rated the stock with a sell rating, nine have issued a hold rating and three have given a buy rating to the stock. The company currently has an average rating of “Hold” and a consensus target price of $57.82.
Cardinal Health (NYSE:CAH) last announced its quarterly earnings data on Monday, May 11th. The company reported $1.62 EPS for the quarter, beating the consensus estimate of $1.43 by $0.19. The business had revenue of $39.16 billion during the quarter, compared to analyst estimates of $37.04 billion. Cardinal Health had a positive return on equity of 69.23% and a negative net margin of 2.71%. The company’s revenue for the quarter was up 11.2% on a year-over-year basis. During the same quarter last year, the firm posted $1.59 earnings per share. On average, analysts expect that Cardinal Health Inc will post 5.3 EPS for the current fiscal year.
The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 15th. Investors of record on Wednesday, July 1st will be paid a dividend of $0.486 per share. The ex-dividend date of this dividend is Tuesday, June 30th. This represents a $1.94 annualized dividend and a yield of 3.79%. This is a positive change from Cardinal Health’s previous quarterly dividend of $0.48. Cardinal Health’s payout ratio is presently 36.36%.
Cardinal Health Company Profile
Cardinal Health, Inc operates as an integrated healthcare services and products company in the United States and internationally. It provides medical products and pharmaceuticals, and solutions that enhance supply chain efficiency for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, and physician offices.
Recommended Story: Determine Your Level of Risk Tolerance
Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health Inc (NYSE:CAH).
Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.